IQVIA Holdings Inc. ( IQV) - Key Metrics
IQV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $26.12 | $1.53 | $3.34 | $2.15 |
| 2026Q1 | $24.65 | $1.63 | $3.67 | $2.92 |
| 2025Q4 | $25.67 | $3.02 | $4.32 | $3.30 |
| 2025Q3 | $24.09 | $1.94 | $5.33 | $7.06 |
| 2025Q2 | $23.38 | $1.55 | $2.58 | $1.70 |
IQV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 31.37 |
| 2026Q1 | 0% | 26.16 |
| 2025Q4 | 0% | 18.66 |
| 2025Q3 | 0% | 24.48 |
| 2025Q2 | 0% | 25.42 |
IQV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.11% | 0% |
| 2026Q1 | 1.71% | 0% |
| 2025Q4 | 1.46% | 0% |
| 2025Q3 | 3.72% | 0% |
| 2025Q2 | 1.08% | 0% |
IQV
Price: $267.77
52 week price:
Payout Ratio Range:
Earnings Per Share: 8.04 USD
P/E Ratio: 29.23
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 286158
Market Capitalization: 43.4 billion